DSGN

Latest SEC Filings & News for DSGN

1 most recent filing and news item mentioning DSGN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/DSGN/news?limit=20"

Pull DSGN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherAug 3, 2026Neutral

Design Therapeutics advances DT-216P2 and reports Q2 2026 results

The company is advancing the RESTORE-FA trial for DT-216P2 and initiating dosing for its DM1 candidate, DT-818, with cash nearing $208 million. The stock is untraded and closed today.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.